Sunmax Biotechnology Co., Ltd. reported earnings results for the third quarter and nine months ended September 30, 2021. For the third quarter, the company reported sales was TWD 252.39 million compared to TWD 193 million a year ago. Revenue was TWD 252.39 million compared to TWD 193 million a year ago. Net income was TWD 41.62 million compared to TWD 18.9 million a year ago. Basic earnings per share from continuing operations was TWD 0.76 compared to TWD 0.35 a year ago. Diluted earnings per share from continuing operations was TWD 0.76 compared to TWD 0.35 a year ago. Basic earnings per share was TWD 0.76 compared to TWD 0.35 a year ago. Diluted earnings per share was TWD 0.76 compared to TWD 0.35 a year ago. For the nine months, sales was TWD 754.18 million compared to TWD 560.02 million a year ago. Revenue was TWD 754.18 million compared to TWD 560.02 million a year ago. Net income was TWD 149.07 million compared to TWD 136.18 million a year ago. Basic earnings per share from continuing operations was TWD 2.74 compared to TWD 2.5 a year ago. Diluted earnings per share from continuing operations was TWD 2.73 compared to TWD 2.5 a year ago. Basic earnings per share was TWD 2.74 compared to TWD 2.5 a year ago. Diluted earnings per share was TWD 2.73 compared to TWD 2.5 a year ago.